The only approved oral GLP-1 drug is Rybelsus, a pill for type 2 diabetes from Novo Nordisk, the same company that makes semaglutide and sells it as Ozempic and Wegovy
What It Is Most weight-management medications act on a single gut hormone pathway
Beta Cells Cells in the pancreas responsible for producing and releasing insulin in response to rising blood glucose levels
Retatrutide is a tri-agonist. It targets three distinct metabolic pathways simultaneously: The addition of Glucagon is what makes Retatrutide fundamentally different from anything currently on the market
Here is why patients trust us: NABH accredited tertiary care hospital NABL accredited laboratory services International quality standards and protocols Advanced diagnostic and treatment facilities Multidisciplinary team approach Patient centric care model Our specialists use evidence based strategies to help manage diabetes, obesity, and metabolic conditions safely and effectively
During your fast, GLP-1 levels will be low as no food has been consumed